A landmark study brings the first good news in decades for children battling a high-risk form of Hodgkin lymphoma. Since the 1960s, survival rates for most pediatric cancers have improved steadily.

Leukemia patients who enroll in LLS's PedAL screening trial and are found to have certain alterations will be directed to receive ziftomenib in a Phase I study.

The new subtrial is evaluating the safety, efficacy and dosing for the treatment of certain acute leukemias in pediatric ...

It is an extraordinary partnership of local, national and international centers of excellence that provides care of treatment for 90 percent of the pediatric hematology ... The diagnosis include ...

BASED on data from the World Health Organization (WHO), around 4,700 new childhood cancer cases among the zero to 19 age ...

Challenges in IndiaDelayed Diagnosis: Awareness about pediatric cancers, including lymphoma, is limited, especially in rural areas. Access to Specialized Treatment: The state-of-the-art facilities ...

HUNTERSVILLE, N.C. — One Huntersville family has made it their mission to spread awareness about pediatric cancer after their son’s own cancer battle. “I hope this is his legacy, I hope that he speaks ...

Walker, Scott Duke Kominers, Ido Paz-Priel, Moody D. Wharam, and Stephanie A. Terezakis. "Patterns of Failure after Involved Field Radiation Therapy for Pediatric and Young Adult Hodgkin Lymphoma." ...

Pediatric cancer patients and their caregivers largely prefer to access test results immediately through the patient portal rather than wait to hear about results from oncologists, according to survey ...

The Burkitt lymphoma market is expected to experience significant growth across the seven major markets (7MM), which include the United States, EU4 (Germany, France, Italy, and Sp ...